Journal of Travel Medicine (J TRAVEL MED)

Publisher: International Society of Travel Medicine; Asia Pacific Travel Health Association, Wiley

Journal description

The Journal of Travel Medicine publishes up-to-date research and original, peer-reviewed articles in the challenging field of travel medicine, including: prevention and treatment of disease; clinic management; patient and staff education; immunizations; impact of travel on host countries; military medicine; problems of refugees; diseases such as malaria, travelers' diarrhea, hepatitis, TB, STDs and AIDS, jet lag, altitude sickness, trauma, special hosts, and more.

Current impact factor: 1.58

Impact Factor Rankings

2015 Impact Factor Available summer 2016
2014 Impact Factor 1.579
2013 Impact Factor 1.525
2012 Impact Factor 1.683
2011 Impact Factor 1.748
2010 Impact Factor 1.473
2009 Impact Factor 1.503
2008 Impact Factor 1.492
2007 Impact Factor 1.048
2006 Impact Factor 1.333
2005 Impact Factor 1.329
2004 Impact Factor 0.766
2003 Impact Factor 0.864
2002 Impact Factor 0.846
2001 Impact Factor 1.164

Impact factor over time

Impact factor

Additional details

5-year impact 1.72
Cited half-life 6.20
Immediacy index 0.52
Eigenfactor 0.00
Article influence 0.43
Website Journal of Travel Medicine website
Other titles Journal of travel medicine (Online), Journal of travel medicine
ISSN 1195-1982
OCLC 60619189
Material type Document, Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publisher details


  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author cannot archive a post-print version
  • Restrictions
    • 12 months embargo
  • Conditions
    • Some journals have separate policies, please check with each journal directly
    • On author's personal website, institutional repositories, arXiv, AgEcon, PhilPapers, PubMed Central, RePEc or Social Science Research Network
    • Author's pre-print may not be updated with Publisher's Version/PDF
    • Author's pre-print must acknowledge acceptance for publication
    • Non-Commercial
    • Publisher's version/PDF cannot be used
    • Publisher source must be acknowledged with citation
    • Must link to publisher version with set statement (see policy)
    • If OnlineOpen is available, BBSRC, EPSRC, MRC, NERC and STFC authors, may self-archive after 12 months
    • If OnlineOpen is available, AHRC and ESRC authors, may self-archive after 24 months
    • Publisher last contacted on 07/08/2014
    • This policy is an exception to the default policies of 'Wiley'
  • Classification
    ​ yellow

Publications in this journal

  • Journal of Travel Medicine 06/2015;
  • Journal of Travel Medicine 01/2015; 22(1). DOI:10.1111/jtm.12177
  • Journal of Travel Medicine 07/2014; 21(4):223-4. DOI:10.1111/jtm.12118
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Sickle cell disease (SCD) is the most common genetic disease among persons with African ancestry. This article provides a background to SCD and reviews many important aspects of travel preparation in this population. Methods: The medical literature was searched for studies on travel-associated preparedness and complications in individuals with SCD. Topics researched included malaria, bacterial infections, vaccinations, dehydration, altitude, air travel, and travel preparedness. Results: There is very little published literature that specifically addresses the risks faced by travelers with SCD. Rates of medical complications during travel appear to be high. There is a body of literature that describes complications of SCD in indigenous populations, particularly within Africa. The generalizability of these data to a traveler is uncertain. Combining these sources of data and the broader medical literature, we address major travel-related questions that may face a provider preparing an individual with SCD for safe travel. Conclusions: Travelers with SCD face considerable medical risks when traveling to developing tropical countries, including malaria, bacterial infections, hypovolemia, and sickle cell-associated vaso-occlusive crises. For individuals with SCD, frank counseling about the risks, vigilant preventative measures, and contingency planning for illness while abroad are necessary aspects of the pre-travel visit.
    Journal of Travel Medicine 06/2014; 21(5). DOI:10.1111/jtm.12142
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Globally, the Swiss have one of the highest proportions of the population traveling to tropical and subtropical countries. Large travel clinics serve an increasing number of customers with specific pre-travel needs including uncommon destinations and preexisting medical conditions. This study aims to identify health characteristics and travel patterns of travelers seeking advice in the largest Swiss travel clinic so that tailored advice can be delivered. Methods: A descriptive analysis was performed on pre-travel visits between July 2010 and August 2012 at the Travel Clinic of the Institute of Social and Preventive Medicine, University of Zurich, Switzerland. Results: A total of 22,584 travelers sought pre-travel advice. Tourism was the main reason for travel (17,875, 81.5%), followed by visiting friends and relatives (VFRs; 1,715, 7.8%), traveling for business (1,223, 5.6%), and "other reasons" (ie, volunteer work, pilgrimage, study abroad, and emigration; 1,112, 5.1%). The main travel destination was Thailand. In the VFR group, the highest proportions of traveling children (258, 15.1%) and of pregnant or breastfeeding women (23, 3.9%) were observed. Mental disorders were more prominent in VFRs (93, 5.4%) and in travel for "other reasons" (63, 5.7%). The latter stayed for the longest periods abroad; 272 (24.9%) stayed longer than 6 months. VFR travelers received the highest percentage of yellow fever vaccinations (523, 30.5%); in contrast, rabies (269, 24.2%) and typhoid vaccinations (279, 25.1%) were given more often to the "other travel reasons" group. Conclusions: New insights into the characteristics of a selected and large population of Swiss international travelers results in improved understanding of the special needs of an increasingly diverse population and, thus, in targeted preventive advice and interventions.
    Journal of Travel Medicine 06/2014; 21(5). DOI:10.1111/jtm.12139
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: In February 2012, crew and passengers of a cruise ship sailing off the coast of São Paulo, Brazil, were hospitalized for acute respiratory illness (ARI). A field investigation was performed to identify the disease involved and factors associated. Methods: Information on passengers and crew with ARI was obtained from the medical records of hospitalized individuals. Active case finding was performed onboard the ship. ARI was defined as the presence of one nonspecific symptom (fever, chills, myalgia, arthralgia, headache, or malaise) and one respiratory symptom (cough, nasal congestion, sore throat, or dyspnea). A case-control study was conducted among the crew. The cases were crew members with symptoms of influenza-like illness (ILI) (fever and one of the following symptoms: cough, sore throat, and dyspnea) in February 2012. The controls were asymptomatic crew members. Results: The study identified 104 ARI cases: 54 (51.9%) crew members and 50 (49.1%) passengers. Among 11 ARI hospitalized cases, 6 had influenza B virus isolated in nasopharyngeal swab. One mortality among these patients was caused by postinfluenza Staphylococcus aureus pneumonia. The crew members housed in the two lower decks and those belonging to the 18- to 32-year-old age group were more likely to develop ILI [odds ratio (OR) = 2.39, 95% confidence interval (CI) 1.09-5.25 and OR = 3.72, CI 1.25-11.16, respectively]. Conclusions: In February 2012, an influenza B outbreak occurred onboard a cruise ship. Among crew members, ILI was associated with lower cabin location and younger age group. This was the first influenza outbreak detected by Brazilian public health authorities in a vessel cruising in South American waters.
    Journal of Travel Medicine 06/2014; 21(5). DOI:10.1111/jtm.12132
  • Journal of Travel Medicine 05/2014; 21(3):220-221.
  • [Show abstract] [Hide abstract]
    ABSTRACT: International travelers were at risk of acquiring influenza A(H1N1)pdm09 (H1N1pdm09) virus infection during travel and importing the virus to their home or other countries. Characteristics of travelers reported to the GeoSentinel Surveillance Network who carried H1N1pdm09 influenza virus across international borders into a receiving country from April 1, 2009, through October 24, 2009, are described. The relationship between the detection of H1N1pdm09 in travelers and the level of H1N1pdm09 transmission in the exposure country as defined by pandemic intervals was examined using analysis of variance (anova). Among the 203 (189 confirmed; 14 probable) H1N1pdm09 case-travelers identified, 56% were male; a majority, 60%, traveled for tourism; and 20% traveled for business. Paralleling age profiles in population-based studies only 13% of H1N1pdm09 case-travelers were older than 45 years. H1N1pdm09 case-travelers sought pre-travel medical advice less often (8%) than travelers with non-H1N1pdm09 unspecified respiratory illnesses (24%), and less often than travelers with nonrespiratory illnesses (43%; p < 0.0001). The number of days from first official H1N1pdm09 case reported by a country to WHO and the first GeoSentinel site report of a H1N1pdm09-exported case in a traveler originated from that country was inversely associated with each country's assigned pandemic interval, or local level of transmission intensity. Detection of travel-related cases appeared to be a reliable indicator of sustained influenza transmission within the exposure country and may aid planning for targeted surveillance, interventions, and quarantine protocols.
    Journal of Travel Medicine 05/2013;
  • Article: Allergy to
    [Show abstract] [Hide abstract]
    ABSTRACT: We describe an allergic reaction to both mouse brain‐derived BIKEN and Vero cell‐derived IXIARO Japanese encephalitis (JE) vaccines in a single traveler. In the absence of the stabilizers and murine proteins in the BIKEN vaccine, a common factor in both vaccines is likely to be responsible, possibly JE virus antigen itself.
    Journal of Travel Medicine 01/2013; 20(1).
  • Source
    Journal of Travel Medicine 01/2013; 20(1). DOI:10.1111/j.1708-8305.2012.00666.x
  • Journal of Travel Medicine 07/2012; 19(4):276-276. DOI:10.1111/j.1708-8305.2012.00632.x
  • [Show abstract] [Hide abstract]
    ABSTRACT: We report three cases of returning travelers evacuated from Algeria, Thailand, and Turkey by aero‐medical repatriation, following overseas hospitalization in local intensive care units for accidental injuries or medical problems. All three patients presented with imipenem‐resistant Acinetobacter baumannii infections. One died whereas two recovered.
    Journal of Travel Medicine 01/2011; 18(5).
  • Journal of Travel Medicine 05/2010; 17(3):181-181. DOI:10.1111/j.1708-8305.2010.00415.x